Epidemiology and diagnosis of hepatitis D virus

Future Virology

Volumn 7, Issue 7, 2012, Pages 709-717

  Niro, Grazia Anna ^a   Fontana, Rosanna ^a   Ippolito, Antonio Massimo ^a   Andriulli, Angelo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

coinfection; drug users; endemicity; HBV vaccine; HDV; HDV RNA; immigration; prevalence

Indexed keywords

HEPATITIS DELTA ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS DNA;

AFRICA; ANTIBODY BLOOD LEVEL; ASIA; DELTA AGENT HEPATITIS; GEOGRAPHY; HEPATITIS B; HEPATITIS C; HEPATITIS DELTA VIRUS; HUMAN; ITALY; MIDDLE EAST; MIGRATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPAIN; TAIWAN; TURKEY (REPUBLIC); VACCINATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

EID: 84864453783     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.61     Document Type: Review

References (65)

1. Rizzetto M, Verme G. Delta hepatitis. J. Hepatol. 1, 187-193 (1985).
2. Taylor JM. Hepatitis delta virus. Virology 344, 71-76 (2006).
3. Su CW, Huang YH, Huo TI et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 130, 1625-1635 (2006).
4. Abbas Z, Jafri W, Raza S. Hepatitis D: Scenario in the Asia-Pacific region. World J. Gastroenterology 16, 554-562 (2010).
5. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: Update and challenges ahead. Nat. Rev. Gastroenterol. Hepatol. 7, 31-40 (2010).
6. Rizzetto M. Hepatitis D: Thirty years after. J. Hepatol. 50, 1043-1050 (2009).
7. Rosina F, Conoscitore P, Cuppone R et al. Changing pattern of chronic hepatitis D in southern Europe. Gastroenterology 117, 161-166 (1999).
8. Verme G, Brunetto MR, Oliveri F et al. Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig. Dis. Sci. 36, 1134-1136 (1991).
9. Laskus T, Radkowski M, Lupa E et al. Introduction of hepatitis delta virus into polish drug community. Infection 20(1), 43-44 (1992).
10. Genné D, Rossi I. Hepatitis delta in Switzerland: A silent epidemic. Swiss Med. Wkly 141, w13176 (2011).
11. Cross TJ, Rizzi P, Horner M et al. The increasing prevalence of hepatitis delta virus (HDV) infection in south London. J. Med. Virol. 80, 277-282 (2008).
12. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection not a vanishing disease in Europe! Hepatology 45, 1331-1332 (2007).
13. Le Gal F, Castelnau C, Gault E et al. Hepatitis D virus infection. Not a vanishing disease in Europe! Hepatology 45, 1332-1333 (2007).
14. Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: Vanishing or refreshing? Hepatology 46, 1312-1313 (2007).
15. De Paschale, Manco MT, Belvisi L et al. Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy. Clinical and epidemiological study. Infection doi:10.1007/s15010-012-0247-0244 (2012) (Epub ahead of print).
16. Flodgren E, Bengtsson S, Knutsson M et al. Recent high incidence of fulminate hepatitis in Samara, Russia: Molecular analysis of prevailing hepatitis B and D virus strains. J. Clin. Microbiol. 38(9), 3311-3316 (2000).
17. Degerteken H, Yalcin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: A meta-analysis. Liver Int. 28, 494-498 (2008).
18. Bahcecioglu IH, Aygun C, Gozel N, Poyrazoglu OK, Bulut Y, Yalniz M. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: Still a serious problem to consider. J. Viral Hepat. 18, 518-524 (2011).
19. Mumtaz K, Hamid SS, Adil S, Afaq A, Islam M, Abid S et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J. Gastroenterol. Hepatol. 20, 1503-1507 (2005).
20. Seetlani NK, Abbas Z, Raza S, Yakoob J, Jafri W. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. J. Pak. Med. Assoc. 59, 434-437 (2009).
21. Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J. Gastroenterol. 13, 2604-2607 (2007).
22. Taghavi SA, Sedighi S, Mehrabani D, Khademolhosseini F. Hepatitis D in chronic active hepatitis B: Prevalence, liver enzyme levels and histopathology. An epidemiological study in Shiraz, southern Iran, 2003-2004. Hepatitis Mon. 8, 248-251 (2008).
23. Gholamreza R, Shahryar S, Abbasali K et al. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J. Med. Sci. 61, 263-268 (2007).
24. Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. J. Med. Virol. 70, 74-80 (2003).
25. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis D virus genotypes in intravenous drug users in Taiwan: Decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J. Clin. Microbiol. 40, 3047-3049 (2002).
26. Arakawa Y, Moriyama M, Taira M et al. Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J. Viral Hepat. 7, 375-381 (2000).
27. Maddrey WC. Hepatitis B: An important public health issue. J. Med. Virol. 61, 362-366 (2000).
28. Casey JL, Niro GA, Engle RE et al. Hepatitis B virus (HBV)/hepatitis D virus (HDV) co infection in outbreaks of acute hepatitis in the Peruvian Amazon basin: The roles of HDV genotype III and HBV genotype F. J. Infect. Dis. 174, 920-926 (1996).
29. Andrade ZA, Lesborders JL, Ravisse P et al. Fulminate hepatitis with microvescicular steatosis (a histological comparison of cases occurring in Brazil-Labrea hepatitis- and in central Africa-Bangui hepatitis). Rev. Soc. Bras. Med. Trop. 25, 155-160 (1992).
30. Parana R, Gerard F, Lesborders JL et al. Serial transmission of spongiocytic hepatitis to woodchucks (a possible association with a specific delta strain). J. Hepatol. 22, 468-473 (1995).
31. Duarte MC, Cardona N, Poblete F et al. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazon's State, Venezuela. Trop. Med. Int. Health 15, 924-933 (2010).
32. Alvarado-Mora MV, Fernandez MF, Gomes-Gouvea MS et al. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis Delta (HDV) viruses in the colombian population - how is the epidemiological situation? PLoS One 6(4), e18888 (2011).
33. Makuwa M, Caron M, Souquiere S, Malonga- Muelet G, Mahé A, Kazanji M. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: Molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J. Clin. Microbiol. 46, 754-756 (2008).
34. Makuwa M, Mintsa-Ndong A, Souquière S, Nkoghé D, Leroy EM, Kazanji M. Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa. J. Clin. Microbiol. 47, 2265-2268 (2009).
35. Foupouapouognigni Y, Noah DN, Sartre MT, Njouom R. High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon. J. Clin. Microbiol. 49, 1162-1164 (2011).
36. Nwokediuko SC, Ijeoma U. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. Niger. J. Clin. Pract. 12, 439-442 (2009).
37. Djebbi A, Rebai WK, Bahri O, Hogga N, Sadraoui A, Triki H. Serological markers, viral RNA and genotype of hepatitis delta virus in HBs antigen positive Tunisian patients. Pathol. Biol. 57, 518-523 (2009).
38. Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B virus and hepatitis C virus co infection. Ann. Clin. Microbiol. Antimicrob. 4, 13 (2005).
39. Quaglio G, Ramadani N, Pattaro C et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: Implications for health policy. J. Med. Virol. 80, 833-840 (2008).
40. Voiculescu M, Iliescu L, Ionescu C et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the sub Carpathian and south-eastern regions of Romania. J. Gastrointestin. Liver Dis. 19, 43-48 (2010).
41. Chang SY, Yang CL, Ko W-S et al. Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan. J. Clin. Microbiol. 49, 1083-1089 (2011).
42. Tsataralt-Od B, Takahashi M, Endo K et al. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: Progress in childhood immunization. J. Med. Virol. 79, 1064-1074 (2007).
43. Kumar AG, Sridharan K, Thirunalasundari T. Prevalence pattern of blood borne hepatitis group of viruses in liver disease patients. World J. Med. Sci. 2, 33-38 (2007).
44. Kahn A, Kurbanov F, Tanaka Y et al. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J. Med. Virol. 80, 268-276 (2008).
45. Oyunsuren T, Kurbanov F, Tanaka Y et al. High frequency of hepatocellular carcinoma in Mongolia: Association with mono-, or co-infection with hepatitis C, B and delta viruses. J. Med. Virol. 78, 1688-1695 (2006).
46. Gaeta GB, Stornaiuolo G, Precone DF et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multi-center Italian study. J. Hepatol. 39, 1036-1041 (2003).
47. Soriano V, Grint D, d'Arminio Monforte A et al. Hepatitis delta in HIV-infected individuals in Europe. AIDS 25(16), 1987-1992 (2011).
48. Shattock AG, Morris MC. Evaluation of commercial enzyme immunoassays for detection of hepatitis delta antigen and anti-hepatitis delta virus (HDV) and immunoglobulin M anti-HDV antibodies. J. Clin. Microbiol. 29, 1873-1876 (1991).
49. Borghesio E, Rosina F, Smedile A et al. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation. Hepatology 27, 873-876 (1998).
50. Mederacke I, Yurdaydin C, Dalekos GN et al. Hep-Net/International Delta Hepatitis Study Group. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: Correlations with disease activity and response to pegylated interferon-a2a treatment. Antivir. Ther. 17(2), 305-312 (2012).
51. Zachou K, Yurdaydin C, Drebber U et al. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int. 30(3), 430-437 (2010).
52. Denniston KJ, Hoyer BH, Smedile A et al. Cloned fragment of hepatitis delta RNA genome, sequence and diagnostic application. Science 232, 873-875 (1986).
53. Smedile A, Niro MG, Rizzetto M. Detection of serum HDV-RNA by RT-PCR. In: nj Methods in Molecular Medicine, Vol 95: HEPATITIS B and D Protocols. Hamatake RK, Lau JYN (Eds). Totowa: HUMANA Press Inc., NJ, USA, 85-93 (2004).
54. Jardi R, Buti M, Cotrina M et al. Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection. Hepatology 21, 25-29 (1995).
55. Niro GA, Smedile A, Andriulli A et al. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology 25, 728-733 (1997).
56. Dény P. Hepatitis delta virus genetic variability: From genotype I, II, III to eight major clades? Curr. Top. Microbiol. Immunol. 307, 151-171 (2006).
57. Radjef N, Gordien E, Ivaniushina V et al. Molecular phylogenetic analyses indicate a wide ancient radiation of African hepatitis delta virus, suggesting a delta virus genus of at least seven major clades. J. Virol. 78, 2537-2544 (2004).
58. Le Gal F, Gordien E, Affolabi D et al. quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J. Clin. Microbiol. 43, 2363-2369 (2005).
59. Yamashiro T, Nagayama K, Enomoto N et al. Quantitative of the level of hepatitis delta virus quantitate RNA in serum, by real-time polymerase chain reaction and its possible correlation with the clinical stage of liver disease. J. Infect. Dis. 189, 1151-1157 (2004).
60. Taylor J, Farci P, Purcell RH. Hepatitis D (delta) virus. In: FIELD'S Virology, 5th edition. Knipe DM, Howley PM (Eds). Lippincott Williams and Wilkins, PA, USA, 3031-3046 (2006).
61. Popper H, Thung SN, Gerber MA et al. Histological studies of severe delta agent infection in Venezuelan Indians. Hepatology 3, 906-912 (1983).
62. Buti M, Esteban R, Jardi R, Esteban JL, Guardia J. Serological diagnosis of acute delta hepatitis. J. Med. Virol. 18, 81-85 (1986).
63. Buti M, Esteban R, Roggendorf M et al. Hepatitis D virus RNA in acute delta infection: Serological profile and correlation with other markers of hepatitis D virus infection. Hepatology 8, 1125-1129 (1988).
64. Bordier BB, Ohkanda J, Liu P et al. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J. Clin. Invest. 112, 407-414 (2003).
65. Glebe D, Urban S, Knoop EV et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129, 234-245 (2005).